Characterization of the aetiological agent in patients with lung tuberculosis

M. V. Chernykh, G. I. Alexeeva (Yakutsk, Russian Federation)

Source: Annual Congress 2006 - Epidemiology of drug resistant tuberculosis
Session: Epidemiology of drug resistant tuberculosis
Session type: E-Posters in free access
Number: 179
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. V. Chernykh, G. I. Alexeeva (Yakutsk, Russian Federation). Characterization of the aetiological agent in patients with lung tuberculosis. Eur Respir J 2006; 28: Suppl. 50, 179

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Characterization of the aetiological agent in patients with pulmonary tuberculosis
Source: Eur Respir J 2006; 28: Suppl. 50, 12s
Year: 2006

Importance of identifying Mycobacterium bovis as a causative agent of human tuberculosis
Source: Eur Respir J 2010; 35: 692-694
Year: 2010


Endobrochites of specific genesis in patients with pulmonary tuberculosis
Source: Eur Respir J 2004; 24: Suppl. 48, 201s
Year: 2004

The prevalance of tuberculosis in patients with lung cancer
Source: Eur Respir J 2004; 24: Suppl. 48, 73s
Year: 2004

Secondary pulmonary mycoses etiology agent species diversity in patients with tuberculosis and in patients with HIV infection
Source: Virtual Congress 2020 – Mechanism or pathways of chronic lung diseases
Year: 2020


Paradoxical reactions in non-HIV tuberculosis presenting as endobronchial obstruction
Source: Eur Respir Rev 2009; 18: 295-299
Year: 2009



Paradoxical response during antibiotic treatment in patients with Mycobacterium avium complex lung disease
Source: Virtual Congress 2020 – Non-tuberculous mycobacterial infections and bronchiectasis
Year: 2020


Association between injectable aminoglycoside treatment duration and outcomes in cavitary Mycobacterium avium complex lung disease
Source: International Congress 2018 – Challenges in treating tuberculosis and nontuberculous mycobacteria
Year: 2018



Accidental detection of mycobacterium tuberculosis infection in patients with various respiratory diseases
Source: Annual Congress 2008 - Epidemiological and clinical aspects of tuberculosis control
Year: 2008


A pathogen in patients with underlying lung disease: corynebacterium pseudodiphtericum
Source: Annual Congress 2008 - Features of hospital-acquired pneumonia, ventilator-associated pneumonia and infection with other pathogens
Year: 2008


The coexistance of active pulmonary tuberculosis in lung cancer patients
Source: Annual Congress 2007 - Epidemiology of tuberculosis II
Year: 2007


Results of drug susceptibility testing of Mycobacterium tuberculosis isolated from sputum and surgical material from pulmonary tuberculosis patients
Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis
Year: 2020


Diagnosis of COPD in patients with multidrug-resistant tuberculosis
Source: International Congress 2018 – COPD around the world
Year: 2018

Risk factors for Mycobacterium tuberculosis infection among contacts of pulmonary tuberculosis patients
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology I
Year: 2012


The peculiarities of drug susceptibility of M. tuberculosis isolated from patients with late-stage HIV infection
Source: International Congress 2019 – Extra-pulmonary tuberculosis and comorbidities
Year: 2019

Method of treatment of destructive tuberculosis of single lung with extensively drug resistant mycobacteria tuberculosis
Source: Annual Congress 2011 - Extrapulmonary tuberculosis and surgical interventions
Year: 2011

Diaskintest at patients after successful treatment of lung tuberculosis
Source: International Congress 2017 – Migrants and screening
Year: 2017


Prevalence of pulmonary tuberculosis in spinal tuberculosis patients
Source: International Congress 2017 – TB: diagnosis, severity and practical management
Year: 2017


Pharmacokinetics of drugs for non tuberculous mycobacterial lung infections
Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings
Year: 2012